Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,374 across all filing types
Latest filing 2023-04-24 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES FIRST PATIENT ENROLLMENT IN CHINA FOR THE MULTI-REGIONAL PHASE 1 TRIAL OF CS5001, A POTENTIAL BEST-IN-CLASS ROR1-TARGETING ADC
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by CStone Pharmaceuticals about the enrollment of the first patient in China for a multi-regional Phase 1 clinical trial of a drug candidate (CS5001). It contains no financial statements, no regulatory form references, no voting results, no management changes, no earnings data, and no detailed financial or governance information. The content focuses on clinical trial progress and company pipeline updates, which is typical for a corporate announcement about clinical development milestones. The document length is 7,876 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication that this is a financial report, regulatory filing, or any other formal report type. Therefore, the best fitting category is a Regulatory Filing (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2023-04-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2023-04-21 English
ELECTION OF STAFF REPRESENTATIVE DIRECTOR OF THE NINTH SESSION OF THE BOARD ANDELECTION OF STAFF REPRESENTATIVE SUPERVISOR OF THE NINTH SESSION OF THE SUPERVISORY COMMITTE
Board/Management Information Classification · 95% confidence The document is an announcement from Yankuang Energy Group Company Limited regarding the election of staff representative directors and supervisors for the ninth session of the Board and Supervisory Committee. It includes biographical details of the elected individuals, their terms, and disclosures related to their appointments. There is no financial data, no discussion of financial results, no mention of annual or interim reports, and no indication of a shareholder vote result announcement. The content focuses on changes in board and supervisory committee membership, which aligns with announcements about changes in senior management or board composition. Therefore, the document fits the category of Board/Management Information (MANG). The document length is substantial (9814 characters), indicating it is a full announcement rather than a brief notice or report publication announcement. Confidence is high due to clear content focus on board and supervisory committee member elections and related disclosures.
2023-04-19 English
PUBLICATION OF THE OPERATIONAL DATA ANNOUNCEMENT FOR THE FIRST QUARTER OF 2023 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANKUANG ENERGY GROUP COMPANY LIMITED
Regulatory Filings Classification · 95% confidence The document is an announcement by Yankuang Energy Group Company Limited regarding the publication of operational data for the first quarter of 2023 of its overseas subsidiary, Yancoal Australia. It provides summary operational data such as production volume, sales volume, and average realized price for the quarter, but does not contain detailed financial statements or comprehensive analysis. The document also directs readers to the full reports published by Yancoal Australia on the ASX and HKEX websites for further details. The document length is short (2392 characters) and it is clearly an announcement of operational data rather than a full interim or quarterly report. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not meet the criteria for an Interim/Quarterly Report (IR) or Earnings Release (ER).
2023-04-19 English
ANNOUNCEMENT ON THE MAJOR OPERATIONAL DATA FOR THE FIRST QUARTER OF 2023
Regulatory Filings Classification · 95% confidence The document is an announcement titled 'ANNOUNCEMENT ON THE MAJOR OPERATIONAL DATA FOR THE FIRST QUARTER OF 2023' by Yankuang Energy Group Company Limited. It provides detailed operational data for the first quarter of 2023, including production and sales volumes for various products. The document is relatively short (4590 characters) and is presented as a voluntary announcement rather than a comprehensive financial report. It does not contain full financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR). Instead, it focuses on operational metrics and explicitly states that the operational data may differ from those disclosed in periodical reports, indicating this is a standalone operational update. Given the nature of the content and length, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories and are not full financial reports.
2023-04-19 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2023-04-19 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.